{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:31:11Z","timestamp":1790483471921,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcyt.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T05:30:15Z","timestamp":1505799015000},"page":"1302-1316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["T cell therapies for human polyomavirus diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Sarah I.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Muranski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003206","article-title":"The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology","volume":"9","author":"White","year":"2013","journal-title":"PLoS Pathog"},{"issue":"Pt 7","key":"10.1016\/j.jcyt.2017.08.011_bib0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/vir.0.020115-0","article-title":"Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians","volume":"91","author":"Antonsson","year":"2010","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0020","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/jmv.23841","article-title":"Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population","volume":"86","author":"Sroller","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/0-387-32957-9_2","article-title":"Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV)","volume":"577","author":"Knowles","year":"2006","journal-title":"Adv Exp Med Biol"},{"issue":"5866","key":"10.1016\/j.jcyt.2017.08.011_bib0030","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrmicro2992","article-title":"A cornucopia of human polyomaviruses","volume":"11","author":"DeCaprio","year":"2013","journal-title":"Nat Rev Micro"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virol.2008.09.027","article-title":"The role of polyomaviruses in human disease","volume":"384","author":"Jiang","year":"2009","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coviro.2012.05.007","article-title":"MCV and Merkel cell carcinoma: a molecular success story","volume":"2","author":"Arora","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13027-017-0122-0","article-title":"Review on the role of the human Polyomavirus JC in the development of tumors","volume":"12","author":"Delbue","year":"2017","journal-title":"Infect Agent Cancer"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.18632\/oncoscience.32","article-title":"Polyomavirus BK and prostate cancer: an unworthy scientific effort?","volume":"1","author":"Delbue","year":"2014","journal-title":"Oncoscience"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0042-6822(92)90167-N","article-title":"Evidence of human polyomavirus BK and JC infection in normal brain tissue","volume":"191","author":"Elsner","year":"1992","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM198607243150405","article-title":"Association of BK viruria with hemorrhagic cystitis in recipients of bone-marrow transplants","volume":"315","author":"Arthur","year":"1986","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0075","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"Clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.jcyt.2017.08.011_bib0085","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2215\/CJN.02770707","article-title":"BK virus nephritis after renal transplantation","volume":"3","author":"Dall","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.jcyt.2017.08.011_bib0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: state of affairs","volume":"87","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178801","article-title":"A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients","volume":"12","author":"Gard","year":"2017","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.011_bib0110","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","article-title":"BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0115","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0120","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0125","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/598335","article-title":"Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study","volume":"48","author":"Khanna","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.011_bib0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrneurol.2016.149","article-title":"HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment","volume":"12","author":"Bowen","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.011_bib0150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.jcyt.2017.08.011_bib0155","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2008.07.006","article-title":"Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?","volume":"8","author":"Molloy","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0165","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4143\/crt.2016.110","article-title":"Progressive multifocal leukoencephalopathy after ibrutinib therapy for chronic lymphocytic leukemia","volume":"49","author":"Lutz","year":"2017","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0170","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/14740338.2016.1198775","article-title":"Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system","volume":"15","author":"Raisch","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12948","article-title":"Progressive multi-focal leucoencephalopathy\u2014driven from rarity to clinical mainstream by iatrogenic immunodeficiency","volume":"188","author":"Misbah","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.22408","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"70","author":"Mateen","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajh.20492","article-title":"Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies","volume":"80","author":"Garcia-Suarez","year":"2005","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0190","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/CVI.05175-11","article-title":"Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus","volume":"18","author":"Viscidi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0195","doi-asserted-by":"crossref","first-page":"e106430","DOI":"10.1371\/journal.pone.0106430","article-title":"Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"26","key":"10.1016\/j.jcyt.2017.08.011_bib0200","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1182\/blood-2010-09-310557","article-title":"Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors","volume":"117","author":"Pancaldi","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcv.2014.10.012","article-title":"High frequency of Merkel cell polyomavirus DNA in the urine of kidney transplant recipients and healthy controls","volume":"61","author":"Signorini","year":"2014","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0210","first-page":"153","article-title":"Merkel cell carcinoma and melanoma: etiological similarities and differences","volume":"8","author":"Miller","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0215","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/000313481508100819","article-title":"Dramatic increase in the incidence and mortality from merkel cell carcinoma in the United States","volume":"81","author":"Fitzgerald","year":"2015","journal-title":"Am Surg"},{"issue":"19","key":"10.1016\/j.jcyt.2017.08.011_bib0220","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-13-0035","article-title":"Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers","volume":"19","author":"Afanasiev","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0225","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1172\/JCI64116","article-title":"Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus","volume":"122","author":"Rodig","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005574","article-title":"The ancient evolutionary history of polyomaviruses","volume":"12","author":"Buck","year":"2016","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jmv.20909","article-title":"non-coding control region rearrangements in health and disease","volume":"79","author":"Sharma","year":"2007","journal-title":"J Med Virol"},{"issue":"20","key":"10.1016\/j.jcyt.2017.08.011_bib0245","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1128\/JVI.00614-10","article-title":"Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate","volume":"84","author":"Gosert","year":"2010","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0250","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1128\/jvi.64.12.5812-5822.1990","article-title":"Identification of critical elements within the JC virus DNA replication origin","volume":"64","author":"Lynch","year":"1990","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrmicro2992","article-title":"A cornucopia of human polyomaviruses","volume":"11","author":"DeCaprio","year":"2013","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2013.08.026","article-title":"Production and biomedical applications of virus-like particles derived from polyomaviruses","volume":"172","author":"Teunissen","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-micro-092611-150154","article-title":"Large T antigens of polyomaviruses: amazing molecular machines","volume":"66","author":"An","year":"2012","journal-title":"Annu Rev Microbiol"},{"issue":"Pt 3","key":"10.1016\/j.jcyt.2017.08.011_bib0270","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1099\/vir.0.008391-0","article-title":"Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies","volume":"90","author":"Randhawa","year":"2009","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcv.2008.01.005","article-title":"BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy","volume":"42","author":"Chen","year":"2008","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0280","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/ajt.13598","article-title":"Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses","volume":"16","author":"Cioni","year":"2016","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0285","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1128\/JVI.02803-12","article-title":"T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors","volume":"87","author":"Jelcic","year":"2013","journal-title":"J Virol"},{"issue":"Pt 10","key":"10.1016\/j.jcyt.2017.08.011_bib0290","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","article-title":"T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus","volume":"87","author":"Li","year":"2006","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0295","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.18632\/oncotarget.12387","article-title":"Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance","volume":"8","author":"Mani","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0300","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.humimm.2009.05.003","article-title":"HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen","volume":"70","author":"Ramaswami","year":"2009","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2006.02.040","article-title":"Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals","volume":"350","author":"Sharma","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/13550289509113966","article-title":"Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA","volume":"1","author":"Trowbridge","year":"1995","journal-title":"J Neurovirol"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0315","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/13550280601009553","article-title":"JC virus T'135, T'136 and T'165 proteins interact with cellular p107 and p130 in vivo and influence viral transformation potential","volume":"12","author":"Bollag","year":"2006","journal-title":"J Neurovirol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/jir198","article-title":"Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity","volume":"204","author":"Gorelik","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0325","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20072097","article-title":"Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology","volume":"205","author":"Gosert","year":"2008","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0330","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1128\/JVI.75.12.5672-5676.2001","article-title":"JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy","volume":"75","author":"Pfister","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0335","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/JCM.01385-15","article-title":"Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing","volume":"53","author":"Sahoo","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002650","article-title":"Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients","volume":"8","author":"Pastrana","year":"2012","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0345","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2009.3","article-title":"Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma","volume":"22","author":"Duncavage","year":"2009","journal-title":"Mod Pathol"},{"issue":"21","key":"10.1016\/j.jcyt.2017.08.011_bib0350","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1158\/1078-0432.CCR-11-1513","article-title":"Merkel cell polyomavirus-specific CD8(+) and CD4(+) T-cell responses identified in Merkel cell carcinomas and blood","volume":"17","author":"Iyer","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0355","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cancers6031267","article-title":"Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus","volume":"6","author":"Stakaityte","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.jcyt.2017.08.011_bib0360","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1128\/JVI.01216-13","article-title":"Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000578","article-title":"Quantitation of human seroresponsiveness to Merkel cell polyomavirus","volume":"5","author":"Pastrana","year":"2009","journal-title":"PLoS Pathog"},{"issue":"21","key":"10.1016\/j.jcyt.2017.08.011_bib0370","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-10-2128","article-title":"Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients","volume":"70","author":"Paulson","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001076","article-title":"Distinct Merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with Merkel cell carcinoma","volume":"6","author":"Laude","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.09.029","article-title":"Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential","volume":"435","author":"Spurgeon","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0385","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2014.10.013","article-title":"Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry","volume":"474","author":"Bennett","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0390","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.onc.1207018","article-title":"Interaction between JCV large T-antigen and beta-catenin","volume":"23","author":"Gan","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0395","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00313028709103889","article-title":"Fibroadenomatosis (fibroadenomatoid mastopathy): a benign breast lesion with composite pathologic features","volume":"19","author":"Hanson","year":"1987","journal-title":"Pathology"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0400","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/glia.20821","article-title":"Glial cell type-specific subcellular localization of 14-3-3 zeta: an implication for JCV tropism","volume":"57","author":"Lamba","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1746-1596-9-65","article-title":"A new in situ hybridization and immunohistochemistry with a novel antibody to detect small T-antigen expressions of Merkel cell polyomavirus (MCPyV)","volume":"9","author":"Matsushita","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0410","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb2602s42","article-title":"BK virus (BKV): infection, propagation, quantitation, purification, labeling, and analysis of cell entry","author":"Moriyama","year":"2009","journal-title":"Curr Protoc Cell Biol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2009.12.024","article-title":"Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma","volume":"398","author":"Nakamura","year":"2010","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0420","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/13550280152537148","article-title":"Distribution and function of JCV agnoprotein","volume":"7","author":"Okada","year":"2001","journal-title":"J Neurovirol"},{"issue":"7","key":"10.1016\/j.jcyt.2017.08.011_bib0425","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/JVI.72.7.6233-6236.1998","article-title":"The agnogene of the human polyomavirus BK is expressed","volume":"72","author":"Rinaldo","year":"1998","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003558","article-title":"The Merkel cell polyomavirus minor capsid protein","volume":"9","author":"Schowalter","year":"2013","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0435","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1128\/JVI.80.5.2083-2091.2006","article-title":"Stability and function of JC virus large T antigen and T' proteins are altered by mutation of their phosphorylated threonine 125 residues","volume":"80","author":"Tyagarajan","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.jcyt.2017.08.011_bib0440","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1158\/1078-0432.CCR-13-2697","article-title":"T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with Merkel cell carcinoma from healthy donors","volume":"20","author":"Lyngaa","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2326-6066.CIR-16-0210","article-title":"Tumor-infiltrating Merkel Cell polyomavirus-specific T Cells are diverse and associated with improved patient survival","volume":"5","author":"Miller","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2009.10.047","article-title":"Global effects of BKV infection on gene expression in human primary kidney epithelial cells","volume":"397","author":"Abend","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0455","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00005072-199803000-00003","article-title":"Overexpression of Ki-67 and cyclins A and B1 in JC virus-infected cells of progressive multifocal leukoencephalopathy","volume":"57","author":"Ariza","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0460","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/jid.2012.445","article-title":"Distinct gene expression profiles of viral- and nonviral-associated Merkel cell carcinoma revealed by transcriptome analysis","volume":"133","author":"Harms","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"19","key":"10.1016\/j.jcyt.2017.08.011_bib0465","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1128\/JVI.77.19.10638-10644.2003","article-title":"JC virus-induced changes in cellular gene expression in primary human astrocytes","volume":"77","author":"Radhakrishnan","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0470","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02079-16","article-title":"Merkel cell polyomavirus exhibits dominant control of the tumor genome and transcriptome in virus-associated merkel cell carcinoma","volume":"8","author":"Starrett","year":"2017","journal-title":"MBio"},{"issue":"133","key":"10.1016\/j.jcyt.2017.08.011_bib0475","doi-asserted-by":"crossref","first-page":"133ra56","DOI":"10.1126\/scitranslmed.3003713","article-title":"Survivin is a therapeutic target in Merkel cell carcinoma","volume":"4","author":"Arora","year":"2012","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0480","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.060689","article-title":"Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy","volume":"170","author":"Pina-Oviedo","year":"2007","journal-title":"Am J Pathol"},{"issue":"35","key":"10.1016\/j.jcyt.2017.08.011_bib0485","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1038\/sj.onc.1204670","article-title":"Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus","volume":"20","author":"Gan","year":"2001","journal-title":"Oncogene"},{"issue":"17\u201318","key":"10.1016\/j.jcyt.2017.08.011_bib0490","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00508-013-0406-3","article-title":"Expression of beta-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck","volume":"125","author":"Lill","year":"2013","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"10.1016\/j.jcyt.2017.08.011_bib0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106257","article-title":"Activation of c-Myc and Cyclin D1 by JCV T-Antigen and beta-catenin in colon cancer","volume":"9","author":"Ripple","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0500","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-009-0533-0","article-title":"Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy","volume":"118","author":"Pina-Oviedo","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0505","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jcp.25238","article-title":"Interaction between human polyomavirus BK and hypoxia inducible factor-1 alpha","volume":"231","author":"Signorini","year":"2016","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0510","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/modpathol.3800717","article-title":"Expression profiles associated with aggressive behavior in Merkel cell carcinoma","volume":"20","author":"Fernandez-Figueras","year":"2007","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CJI.0000000000000119","article-title":"MAGE-A is more highly expressed than NY-ESO-1 in a systematic immunohistochemical analysis of 3668 cases","volume":"39","author":"Kerkar","year":"2016","journal-title":"J Immunother"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0520","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.18632\/oncotarget.6494","article-title":"Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy","volume":"7","author":"Goh","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2015.04.002","article-title":"Correlation of Merkel cell polyomavirus positivity with PDGFRalpha mutations and survivin expression in Merkel cell carcinoma","volume":"79","author":"Batinica","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0530","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/jcp.25047","article-title":"Animal models for progressive multifocal leukoencephalopathy","volume":"230","author":"White","year":"2015","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0535","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.coviro.2012.06.004","article-title":"Patterns of polyomavirus SV40 infections and associated cancers in humans: a model","volume":"2","author":"Butel","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"19","key":"10.1016\/j.jcyt.2017.08.011_bib0540","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1128\/JVI.01095-10","article-title":"Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen","volume":"84","author":"Lowe","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000924","article-title":"NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors","volume":"6","author":"Mishra","year":"2010","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0550","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00005072-199205000-00003","article-title":"Expression of major histocompatibility complex antigens in the brains of patients with progressive multifocal leukoencephalopathy","volume":"51","author":"Achim","year":"1992","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0555","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2015.00307","article-title":"Polyomavirus-specific cellular immunity: from BK-virus-specific cellular immunity to BK-virus-associated nephropathy?","volume":"6","author":"Dekeyser","year":"2015","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0560","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2011.01.008","article-title":"An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination","volume":"9","author":"Bauman","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"13","key":"10.1016\/j.jcyt.2017.08.011_bib0565","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.18632\/oncotarget.8085","article-title":"Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity","volume":"7","author":"Bauman","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0570","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/TP.0b013e3181bc6096","article-title":"Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients","volume":"89","author":"Womer","year":"2010","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0575","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1399-0012.2005.00405.x","article-title":"The effects of renal transplantation on peripheral blood dendritic cells","volume":"19","author":"Womer","year":"2005","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2017.02.013","article-title":"Natural killer cell response is a predictor of good outcome in MCPyV+ Merkel cell carcinoma: a case series of 23 patients","volume":"77","author":"Laniosz","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.011_bib0585","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/2326-6066.CIR-14-0005","article-title":"Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma","volume":"2","author":"Paulson","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0590","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaad.2011.09.002","article-title":"Merkel cell carcinoma induces lymphatic microvessel formation","volume":"67","author":"Werchau","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0595","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000444317","article-title":"Merkel cell carcinoma with spontaneous regression: a case report and immunohistochemical study","volume":"8","author":"Terui","year":"2016","journal-title":"Case Rep Dermatol"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0600","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0605","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcv.2008.06.009","article-title":"BK virus antibody titers and intensity of infections after renal transplantation","volume":"43","author":"Bohl","year":"2008","journal-title":"J Clin Virol"},{"issue":"22","key":"10.1016\/j.jcyt.2017.08.011_bib0610","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.011_bib0615","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CVI.00123-07","article-title":"Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored","volume":"14","author":"Leuenberger","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/0-387-32957-9_5","article-title":"Serological cross reactivity between polyomavirus capsids","volume":"577","author":"Viscidi","year":"2006","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0625","first-page":"278","article-title":"Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays","volume":"10","author":"Viscidi","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"21","key":"10.1016\/j.jcyt.2017.08.011_bib0630","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jnci\/djp332","article-title":"Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma","volume":"101","author":"Carter","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0635","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/JVI.01512-09","article-title":"Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase","volume":"84","author":"Lowe","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.011_bib0640","doi-asserted-by":"crossref","DOI":"10.3390\/v8050128","article-title":"Divergent trends of anti-JCPyV serum reactivity and neutralizing activity in multiple sclerosis (MS) patients during treatment with natalizumab","volume":"8","author":"Diotti","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0645","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.virol.2015.08.022","article-title":"BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients","volume":"485","author":"Rossi","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.011_bib0650","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant Direct"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0655","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"neutralizing activity in human immunoglobulin preparations","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"issue":"14","key":"10.1016\/j.jcyt.2017.08.011_bib0660","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.02506-10","article-title":"Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome","volume":"85","author":"Gheuens","year":"2011","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0665","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2010.30.6308","article-title":"Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival","volume":"29","author":"Paulson","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0670","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/TP.0000000000001314","article-title":"Increased frequency of BK virus-specific polyfunctional CD8+ T cells predict successful control of BK viremia after kidney transplantation","volume":"101","author":"Schaenman","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0675","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1479-5876-10-248","article-title":"JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients","volume":"10","author":"Mancuso","year":"2012","journal-title":"J Transl Med"},{"issue":"18","key":"10.1016\/j.jcyt.2017.08.011_bib0680","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.1128\/JVI.01540-13","article-title":"Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults","volume":"87","author":"van Aalderen","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0685","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00430-014-0348-z","article-title":"The role of CD4(+) T cells in BKV-specific T cell immunity","volume":"203","author":"Weist","year":"2014","journal-title":"Med Microbiol Immunol"},{"issue":"14","key":"10.1016\/j.jcyt.2017.08.011_bib0690","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1128\/JVI.00543-11","article-title":"CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA","volume":"85","author":"Aldrich","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0695","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2015.00159","article-title":"Immune system involvement in the pathogenesis of JC virus induced PML: what is learned from studies of patients with underlying diseases and therapies as risk factors","volume":"6","author":"Monaco","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0700","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/vim.2007.0030","article-title":"Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults","volume":"20","author":"Zhou","year":"2007","journal-title":"Viral Immunol"},{"issue":"7","key":"10.1016\/j.jcyt.2017.08.011_bib0705","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11864-016-0409-1","article-title":"Merkel cell carcinoma therapeutic update","volume":"17","author":"Cassler","year":"2016","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0710","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.jcyt.2017.08.011_bib0715","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell Carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jcyt.2017.08.011_bib0720","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"issue":"242","key":"10.1016\/j.jcyt.2017.08.011_bib0725","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0730","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-3062.2009.00458.x","article-title":"Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population","volume":"12","author":"Perez-Torres","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.jcyt.2017.08.011_bib0735","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.transproceed.2014.11.051","article-title":"Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients","volume":"47","author":"Yoon","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0740","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtm.2017.02.001","article-title":"Toward a rapid production of multivirus-specific T cells targeting BKV, adenovirus, CMV, and EBV from umbilical cord blood","volume":"5","author":"Dave","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0745","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/TP.0b013e31823328c0","article-title":"BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses","volume":"92","author":"Blyth","year":"2011","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jcyt.2017.08.011_bib0750","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcyt.2014.04.003","article-title":"Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation","volume":"16","author":"Mani","year":"2014","journal-title":"Cytotherapy"},{"issue":"22","key":"10.1016\/j.jcyt.2017.08.011_bib0755","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood.V128.22.504.504","article-title":"Efficacy of third party BK virus (BKV) specific cytotoxic T-Lymphocytes generated By Ex Vivo expansion for the treatment of BKV infection in stem cell transplant recipients, a phase 2 trial","volume":"128","author":"Olson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0760","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001698","article-title":"Clinical-scale rapid autologous BK-virus specific T cell line generation from kidney transplant recipients with active viremia for adoptive immunotherapy","author":"Lamarche","year":"2017","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0765","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"20","key":"10.1016\/j.jcyt.2017.08.011_bib0770","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.011_bib0775","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s13365-015-0316-4","article-title":"Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"Dong-Si","year":"2015","journal-title":"J Neurovirol"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.011_bib0780","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/cid\/ciu682","article-title":"Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1","volume":"59","author":"Sospedra","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jcyt.2017.08.011_bib0785","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/bmt.2010.221","article-title":"Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient","volume":"46","author":"Balduzzi","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0790","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/2326-6066.CIR-13-0087","article-title":"Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I","volume":"2","author":"Chapuis","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jcyt.2017.08.011_bib0795","series-title":"Adoptive cellular therapy (ACT) with allogeneic activated natural killer (aNK) cells in patients with advanced Merkel cell carcinoma (MCC): preliminary results of a phase II trial","first-page":"80","author":"Bhatia","year":"2016"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.011_bib0800","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm.4015","article-title":"Prospects for gene-engineered T cell immunotherapy for solid cancers","volume":"22","author":"Klebanoff","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.011_bib0805","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.coi.2009.02.004","article-title":"Adoptive immunotherapy of cancer using CD4(+) T cells","volume":"21","author":"Muranski","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2017.08.011_bib0810","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncponc0666","article-title":"Increased intensity lymphodepletion and adoptive immunotherapy\u2013how far can we go?","volume":"3","author":"Muranski","year":"2006","journal-title":"Nat Clin Pract Oncol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:32:41Z","timestamp":1761442361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917306709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":161,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1465324917306709"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.011","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell therapies for human polyomavirus diseases","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for Cellular Therapy.","name":"copyright","label":"Copyright"}]}}